What question did this study set out to answer?

This research aims to explore the clinical features and treatment outcomes of brain metastases in differentiated thyroid carcinoma.

April 11, 2026

Ver artículo completo

Brain Metastases in Differentiated Thyroid Carcinoma: Clinical Features, Treatment Outcomes, and the Role of Radioiodine Therapy

YKYogita KhandelwalAll India Institute of Medical Sciences SSSwayamjeet Satapathy CBC. BalAll India Institute of Medical Sciences

Puntos clave

This research aims to explore the clinical features and treatment outcomes of brain metastases in differentiated thyroid carcinoma.
Analyzed clinical characteristics of patients with brain metastases from differentiated thyroid carcinoma.
Evaluated the effectiveness of radioiodine therapy on these patients.
Emphasized the importance of individualized treatment strategies.
Brain metastases in differentiated thyroid carcinoma were found to be uncommon but associated with a poor prognosis.
Some patients exhibited durable responses to radioiodine therapy.
No statistically significant survival advantage was established from the treatment.

Resumen

BM from DTC are uncommon but confer poor prognosis. Durable responses were observed with RAI in a selected subset, but no statistically significant survival advantage could be demonstrated. Individualised multimodality management is essential.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Khandelwal et al. (Wed,) studied this question.

synapsesocial.com/papers/69d9e5d178050d08c1b75fa3 https://doi.org/https://doi.org/10.1111/cen.70142

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo